Rhythm Pharmaceuticals
RYTM
RYTM
80 hedge funds and large institutions have $621M invested in Rhythm Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-9
Holders Change %
-10.11%
% of All Funds
1.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
15
Increased
28
Reduced
21
Closed
23
Calls
$1K
Puts
$19K
Net Calls
-$18K
Net Calls Change
-$18K
Top Buyers
| 1 |
Primecap Management
Pasadena,
California
|
+$22.1M |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$4.21M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$2.36M |
| 4 |
Aviva
London,
United Kingdom
|
+$2.02M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.64M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.2M |
| 2 |
DM
Deerfield Management
New York
|
-$19.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.54M |
